Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Coronavirus: ‘Germany not for sale,’ says minister after ‘US tried to buy vaccine rights’

Coronavirus: ‘Germany not for sale,’ says minister after ‘US tried to buy vaccine rights’

US allegedly offered local firm CureVac US$1 billion for exclusive rights to vaccine, according to German newspaper. Company denies receiving offer from US government and declines to give details about surprise change in CEO

Germany's economy minister has a message for the United States in a row that has emerged over coronavirus vaccine access: “Germany is not for sale.”

Minister Peter Altmaier, a close ally of Chancellor Angela Merkel, delivered the message in English on Monday in a podcast hosted by prominent German journalist Gabor Steingart.

Citing government sources in Berlin, the Sunday edition of the mass-circulation Die Welt newspaper reported that the US had offered CureVac, a private firm based in Tuebingen, 30km (19 miles) south of Stuttgart, US$1 billion for exclusive rights to a vaccine that it is developing.

“We know this company, [and] we are in touch with this company,” Altmaier said in the podcast interview, which was conducted in German.



However, CureVac denied that any offer had been made.

“CureVac has not received from the US government or related entities an offer before, during and since the Task Force meeting in the White House on March 2. CureVac rejects all allegations from [the] press,” the company said in a tweet.

A CureVac spokesperson would not give details about last week's surprise change in management, which saw Daniel Menichella replaced as chief executive by CureVac founder Ingmar Hoerr.

In early March Menichella, a US citizen, visited the White House at the invitation of President Donald Trump to discuss strategies for vaccine development, together with other pharmaceutical and biotech companies.

CureVac is currently working on a coronavirus vaccine and has received US$8.3 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), an international alliance.

Once a suitable vaccine has been found and tested in clinical trials, CureVac intends to produce the drug itself.

According to the company spokesperson, it is not clear whether CureVac would sell the rights to the vaccine, conclude an external contract or market the drug itself.



“We are not bound by any agreements,” he said.

European Commission President Ursula von der Leyen spoke with executives from the German pharmaceutical company on Monday, writing on Twitter that the European Union would offer financial support to the firm as it had done in the past.

It is “crucial to find a vaccine that will help the whole world”, she wrote.

Despite the company's denial of any US offer, German government ministers were quick to confirm that they had been informed about the reported sum.

“German researchers are leaders in the development of medicines and vaccines, in global collaborations. We cannot allow others to exclusively acquire their research results,” Foreign Minister Heiko Maas told the newspapers of the Funke media group.

“We will only defeat this virus together, not against each other,” Maas asserted.

AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
House Republicans Move to Defund OECD Over Global Tax Dispute
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
Intel Reports Revenue Beats but Sees 81% Rise in Losses
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
President Trump Diagnosed with Chronic Venous Insufficiency After Leg Swelling
CEO Resigns Amid Controversy Over Relationship with HR Executive
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
Tulsi Gabbard Unveils Evidence Alleging Political Manipulation of Intelligence During Trump Administration
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Trump Announces Coca-Cola to Shift to Cane Sugar in U.S. Production
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Air India Pilot’s Mental Health Records Under Scrutiny
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
Moonshot AI Unveils Kimi K2: A New Open-Source AI Model
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Bitcoin Reaches New Milestone of $116,000
Severe Heatwave Claims 2,300 Lives Across Europe
Declining Beer Consumption Signals Cultural Shift in Germany
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
Western Europe Records Hottest June on Record
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
China’s Central Bank Consults European Peers on Low-Rate Strategies
France Requests Airlines to Cut Flights at Paris Airports Amid Planned Air Traffic Controller Strike
Poland Implements Border Checks Amid Growing Migration Tensions
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
×